Literature DB >> 19336815

Central bone grafting for nonunion of fractures of the tibia: a retrospective series.

M Ryzewicz1, S J Morgan, E Linford, J I Thwing, G V P de Resende, W R Smith.   

Abstract

Nonunion of the tibia associated with bone loss, previous infection, obliteration of the intramedullary canal or located in the distal metaphysis poses a challenge to the surgeon and significant morbidity to patients. We retrospectively reviewed the records of 24 patients who were treated by central bone grafting and compared them to those of 20 who were treated with a traditional posterolateral graft. Central bone grafting entails a lateral approach, anterior to the fibula and interosseous membrane which is used to create a central space filled with cancellous iliac crest autograft. Upon consolidation, a tibiofibular synostosis is formed that is strong enough for weight-bearing. This procedure has advantages over other methods of treatment for selected nonunions. Of the 24 patients with central bone grafting, 23 went on to radiographic and clinical union without further intervention. All healed within a mean of 20 weeks (10 to 48). No further bone grafts were required, and few complications were encountered. These results were comparable to those of the 20 patients who underwent posterolateral bone grafting who united at a mean of 31.3 weeks (16 to 60) but one of whom required below-knee amputation for intractable sepsis. Central bone grafting is a safe and effective treatment for difficult nonunions of the tibia.

Entities:  

Mesh:

Year:  2009        PMID: 19336815     DOI: 10.1302/0301-620X.91B4.21399

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  9 in total

Review 1.  The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease.

Authors:  Michael Hadjiargyrou; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

2.  Role of Huntington procedure as a limb salvage surgery for complex gap nonunion of tibia in children.

Authors:  Abdul Qayyum Khan; Yasir Salam Siddiqui; Mazhar Abbas; Aamir Bin Sabir
Journal:  J Clin Orthop Trauma       Date:  2021-04-19

3.  Autogenous iliac crest bone grafting for tibial nonunions revisited: does approach matter?

Authors:  Sanjit R Konda; Connor P Littlefield; Kurtis D Carlock; Abhishek Ganta; Philipp Leucht; Kenneth A Egol
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-08       Impact factor: 3.067

Review 4.  Autologous bone graft in the treatment of post-traumatic bone defects: a systematic review and meta-analysis.

Authors:  Matheus Lemos Azi; Alessandro Aprato; Irene Santi; Mauricio Kfuri; Alessandro Masse; Alexander Joeris
Journal:  BMC Musculoskelet Disord       Date:  2016-11-09       Impact factor: 2.362

5.  Gene activated adipose tissue fragments as advanced autologous biomaterials for bone regeneration: osteogenic differentiation within the tissue and implications for clinical translation.

Authors:  Bin Ren; Volker M Betz; Christian Thirion; Michael Salomon; Roland M Klar; Volkmar Jansson; Peter E Müller; Oliver B Betz
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

6.  Minimally Invasive Percutaneous Plate Osteosynthesis (MIPPO) Combined with Onionskin-Like Autologous Bone Grafting: A New Technique for Treatment of Tibial Nonunion.

Authors:  Dankai Wu; Fengmin Mao; Baoming Yuan; Guangkai Ren; He Liu; Chuangang Peng
Journal:  Med Sci Monit       Date:  2019-08-12

7.  Gap nonunion of tibia treated by Huntington's procedure.

Authors:  Zile S Kundu; Vinay Gupta; Sukhbir S Sangwan; Pardeep Kamboj
Journal:  Indian J Orthop       Date:  2012-11       Impact factor: 1.251

8.  Evaluation of injectable constructs for bone repair with a subperiosteal cranial model in the rat.

Authors:  Marta Kisiel; Agnieszka S Klar; Mikaël M Martino; Manuela Ventura; Jöns Hilborn
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

9.  Infected nonunion of tibia.

Authors:  Milind Madhav Chaudhary
Journal:  Indian J Orthop       Date:  2017 May-Jun       Impact factor: 1.251

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.